Delivery Order SPE2DB20D9127-SPE2DB22FD3SY

Award Date 4/4/22
Potential Completion Date 4/25/22
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,149.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4564814368 Kyleena 19.5 mg systems, a contraceptive device. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which enables the DLA to issue firm fixed-price...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,062.08 firm fixed-price delivery order is for the supply of the contraceptive device Kyleena (19.5 mg systems), with a performance period through July 6, 2023. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,024.70 firm fixed-price delivery order is for the supply of the contraceptive device Kyleena 19.5mg System. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This IDC enables the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a $4,815.36 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of the contraceptive device KYLEENA 19.5 MG SYSTEMS. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, valued up to $4,999,999, that DMS Pharmaceutical Group holds with DLA to provide a wide range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,419.76 firm fixed-price delivery order is for the supply of the contraceptive device Kyleena, with a period of performance through September 11, 2024. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,929.60 firm fixed-price delivery order is for the supply of the Kyleena 19.5 mg contraceptive system. The award is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to order a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,256.80 firm fixed-price delivery order contract is for the supply of the contraceptive device Kyleena 19.5 mg systems, with a period of performance through August 30, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,889.10, is for the delivery of Kyleena 19.5 MG Systems, a contraceptive device, to support the recurring medical supply needs of military health facilities worldwide. This contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,024.70 firm fixed-price delivery order is for the supply of KYLEENA 19.5 MG SYSTEMS, a contraceptive device. The award is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award...
This federal contract award, valued at $13,723.92, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4,566,759,561 units of the Kyleena 19.5 mg contraceptive system. The contract has an ultimate completion date of December 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 between DMS...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB22FD3SY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,543.20 fixed-price delivery order is for the supply of the contraceptive device Kyleena 19.5 mg Systems.

DMS Pharmaceutical Group Inc. holds a large single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders to DMS Pharmaceutical Group for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, enabling DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories.

Generated 2/27/25, 12:45 PM